John Sims
Psychiatry & Neurology / Neurology
Credentials: · ·
History
Research
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
JAMA · 2023 · First of 20 authors · 2,315 citations
Donanemab in Early Alzheimer's Disease
New England Journal of Medicine · 2021 · 1,335 citations
ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes
Neurology · 2009 · First of 7 authors · Corresponding · 361 citations
- MM
15 papers
12 papers
- RY
11 papers
- JZ
10 papers
- RS
9 papers
9 papers
5 papers
5 papers
